R&D
Purespring on nephrology & gene therapy in kidney disease
Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.
Digital
The cliff was never the crisis: Pharma’s strategy problem
The patent cliff isn't the problem. It's the symptom.
R&D
Sponsored
What European Commission marketing authorisation of a teripa...
Biosimilars can help support broader patient access while contributing to the long-term sustainability of healthcare systems.
R&D
Why critical-care injectables are among the hardest medicine...
When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl
Market Access
Changing Faces: Boards of Directors and Advisory Boards, May...
The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
